Skip to main content
. 2018 Jun 19;9(47):28547–28560. doi: 10.18632/oncotarget.25558

Figure 7. PTC596-induced apoptosis is enhanced by combination with ibrutinib in primary cells.

Figure 7

Primary MCL and CLL cells from patients were incubated for 24 hours with 2 μM ibrutinib and 2 μM PTC596, either as individual agents or in combination, and phosphatidylserine externalization was assessed by flow cytometry.